HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Therapy of chronic urticaria and recurrent Quincke edema].

Abstract
A rational and differential therapy of chronic urticaria and relapsing angioedema must be based on a precise classification of the disease. The general management as well as the specific therapy will have to consider the various trigger factors involved, the differences in the response rates to antiallergic drugs and the different prognoses of the urticaria subforms. Therefore this article will first briefly describe the most frequent subforms of urticaria and relapsing angioedema, and then discuss their management and treatment.
AuthorsT M Kündig
JournalTherapeutische Umschau. Revue therapeutique (Ther Umsch) Vol. 58 Issue 5 Pg. 321-4 (May 2001) ISSN: 0040-5930 [Print] Switzerland
Vernacular TitleTherapie der chronischen Urtikaria und der rezidivierenden Quincke-Odeme.
PMID11407235 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Anti-Allergic Agents
Topics
  • Angioedema (drug therapy, etiology)
  • Anti-Allergic Agents (adverse effects, therapeutic use)
  • Chronic Disease
  • Humans
  • Recurrence
  • Urticaria (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: